These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 22589061)

  • 1. Model membrane platforms for biomedicine: case study on antiviral drug development.
    Jackman JA; Cho NJ
    Biointerphases; 2012 Dec; 7(1-4):18. PubMed ID: 22589061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System.
    Nakajima S; Watashi K; Ohashi H; Kamisuki S; Izaguirre-Carbonell J; Kwon AT; Suzuki H; Kataoka M; Tsukuda S; Okada M; Moi ML; Takeuchi T; Arita M; Suzuki R; Aizaki H; Kato T; Suzuki T; Hasegawa H; Takasaki T; Sugawara F; Wakita T
    J Virol; 2016 Oct; 90(20):9058-74. PubMed ID: 27489280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of an amphipathic alpha-helical peptide's antiviral activity involves size-dependent virus particle lysis.
    Cho NJ; Dvory-Sobol H; Xiong A; Cho SJ; Frank CW; Glenn JS
    ACS Chem Biol; 2009 Dec; 4(12):1061-7. PubMed ID: 19928982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication.
    Berger C; Romero-Brey I; Radujkovic D; Terreux R; Zayas M; Paul D; Harak C; Hoppe S; Gao M; Penin F; Lohmann V; Bartenschlager R
    Gastroenterology; 2014 Nov; 147(5):1094-105.e25. PubMed ID: 25046163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphipathic helix-dependent localization of NS5A mediates hepatitis C virus RNA replication.
    Elazar M; Cheong KH; Liu P; Greenberg HB; Rice CM; Glenn JS
    J Virol; 2003 May; 77(10):6055-61. PubMed ID: 12719597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction networks of hepatitis C virus NS4B: implications for antiviral therapy.
    Li S; Yu X; Guo Y; Kong L
    Cell Microbiol; 2012 Jul; 14(7):994-1002. PubMed ID: 22329740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding dynamics of hepatitis C virus' NS5A amphipathic peptide to cell and model membranes.
    Cho NJ; Cheong KH; Lee C; Frank CW; Glenn JS
    J Virol; 2007 Jun; 81(12):6682-9. PubMed ID: 17428867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells.
    Wolfisberg R; Holmbeck K; Nielsen L; Kapoor A; Rice CM; Bukh J; Scheel TKH
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31292246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular virology of hepatitis C virus: an update with respect to potential antiviral targets.
    Blight KJ; Kolykhalov AA; Reed KE; Agapov EV; Rice CM
    Antivir Ther; 1998; 3(Suppl 3):71-81. PubMed ID: 10726057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daclatasvir Prevents Hepatitis C Virus Infectivity by Blocking Transfer of the Viral Genome to Assembly Sites.
    Boson B; Denolly S; Turlure F; Chamot C; Dreux M; Cosset FL
    Gastroenterology; 2017 Mar; 152(4):895-907.e14. PubMed ID: 27932311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Small Molecule Inhibits Hepatitis C Virus Propagation in Cell Culture.
    Oraby AK; Gardner CL; Needle RF; Kofahi HM; Everard KR; Taylor NGA; Rutihinda SG; Barry JP; Hirasawa K; Georghiou PE; Russell RS
    Microbiol Spectr; 2021 Sep; 9(1):e0043921. PubMed ID: 34319169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical Measurement Strategies for Antiviral Drug Development: Recent Progress in Virus-Mimetic Platforms Down to the Single Particle Level.
    Park S; Tae H; Cho NJ
    Acc Chem Res; 2021 Aug; 54(16):3204-3214. PubMed ID: 34346210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hepatitis C virus NS5A inhibitor (BMS-790052) alters the subcellular localization of the NS5A non-structural viral protein.
    Lee C; Ma H; Hang JQ; Leveque V; Sklan EH; Elazar M; Klumpp K; Glenn JS
    Virology; 2011 May; 414(1):10-8. PubMed ID: 21513964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Priming of Antiviral CD8 T Cells without Effector Function by a Persistently Replicating Hepatitis C-Like Virus.
    Hartlage AS; Walker CM; Kapoor A
    J Virol; 2020 May; 94(10):. PubMed ID: 32102885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An N-terminal amphipathic helix in hepatitis C virus (HCV) NS4B mediates membrane association, correct localization of replication complex proteins, and HCV RNA replication.
    Elazar M; Liu P; Rice CM; Glenn JS
    J Virol; 2004 Oct; 78(20):11393-400. PubMed ID: 15452261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C Virus Replication Depends on Endosomal Cholesterol Homeostasis.
    Stoeck IK; Lee JY; Tabata K; Romero-Brey I; Paul D; Schult P; Lohmann V; Kaderali L; Bartenschlager R
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane association of hepatitis C virus nonstructural proteins and identification of the membrane alteration that harbors the viral replication complex.
    Moradpour D; Gosert R; Egger D; Penin F; Blum HE; Bienz K
    Antiviral Res; 2003 Oct; 60(2):103-9. PubMed ID: 14638405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral stilbene 1,2-diamines prevent initiation of hepatitis C virus RNA replication at the outset of infection.
    Gastaminza P; Pitram SM; Dreux M; Krasnova LB; Whitten-Bauer C; Dong J; Chung J; Fokin VV; Sharpless KB; Chisari FV
    J Virol; 2011 Jun; 85(11):5513-23. PubMed ID: 21430055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library.
    Hernandez-Morales I; Geluykens P; Clynhens M; Strijbos R; Goethals O; Megens S; Verheyen N; Last S; McGowan D; Coesemans E; De Boeck B; Stoops B; Devogelaere B; Pauwels F; Vandyck K; Berke JM; Raboisson P; Simmen K; Lory P; Van Loock M
    Antiviral Res; 2017 Nov; 147():149-158. PubMed ID: 29037976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A.
    Helbig KJ; Eyre NS; Yip E; Narayana S; Li K; Fiches G; McCartney EM; Jangra RK; Lemon SM; Beard MR
    Hepatology; 2011 Nov; 54(5):1506-17. PubMed ID: 22045669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.